CAS 77229-68-6
:4-[(6-methoxyquinolin-8-yl)amino]pentanoic acid
Description:
4-[(6-Methoxyquinolin-8-yl)amino]pentanoic acid, with the CAS number 77229-68-6, is a chemical compound characterized by its unique structure that includes a quinoline moiety and an amino acid component. This compound features a pentanoic acid backbone, which contributes to its potential as a bioactive molecule. The presence of the methoxy group on the quinoline ring enhances its solubility and may influence its biological activity. The amino group allows for potential interactions with biological targets, making it of interest in medicinal chemistry. This compound may exhibit properties such as antimicrobial, anti-inflammatory, or anticancer activities, although specific biological effects would depend on further empirical studies. Its molecular structure suggests it could participate in hydrogen bonding and other interactions, which are crucial for its reactivity and functionality in various chemical environments. As with many compounds containing heterocyclic rings, it may also display unique spectral characteristics useful for identification and analysis in research settings.
Formula:C15H18N2O3
InChI:InChI=1/C15H18N2O3/c1-10(5-6-14(18)19)17-13-9-12(20-2)8-11-4-3-7-16-15(11)13/h3-4,7-10,17H,5-6H2,1-2H3,(H,18,19)
SMILES:CC(CCC(=O)O)Nc1cc(cc2cccnc12)OC
Synonyms:- 8-(3-Carboxy-1-Methylpropylamino)-6-Methoxyquinoline
- Carboxyprimaquine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Carboxy Primaquine-d4 (Major)
CAS:Controlled ProductFormula:C15H14D4N2O3Color and Shape:NeatMolecular weight:278.34Carboxy Primaquine
CAS:Controlled Product<p>Applications Carboxy Primaquine, is a derivative of Primaquine (P733500), an Antimalarial agent.<br>References Marrs, T., et al.: Toxicol Lett., 36, 281 (1987), Karbwang, J., et al.: Clin. Pharmacokinetic., 27, 104 (1994), Noedl, H., et al.: Antimicrob. Agents Chemother., 45, 2106 (2010)<br></p>Formula:C15H18N2O3Color and Shape:NeatMolecular weight:274.32Carboxy Primaquine
CAS:<p>Carboxy Primaquine is an antimicrobial agent that inhibits the activity of cytochrome P450 enzymes. It is used to treat malaria, as it has potent anti-malarial activity against Plasmodium falciparum and Plasmodium vivax. Carboxy Primaquine is also used to treat other protozoal and bacterial infections, such as toxoplasmosis, pneumocystosis, leishmaniasis, trypanosomiasis, and leptospirosis. This drug has been shown to have immunogenic properties in vivo in humans. Inhibition of carboxyprimaquine metabolism by glucuronide conjugates has been demonstrated in liver cells from humans and rats. The pharmacokinetic profile of this drug includes a rapid absorption from the gastrointestinal tract, followed by a terminal elimination phase with a half-life of approximately 2 hours. Carboxy Primaquine is not carcinogenic in animal models</p>Formula:C15H18N2O3Purity:Min. 95 Area-%Color and Shape:PowderMolecular weight:274.32 g/mol



